New paper (method D for PE 0.90) [Two-Stage / GS Designs]

posted by ElMaestro  – Denmark, 2011-04-19 16:49 (5178 d 03:19 ago) – Posting: # 6922
Views: 26,278

Dear d_labes,

❝ What makes me also wondering is that the alpha "inflation" is shifted to higher stage 1 number of subjects if the variability increases. This is somehow counter-intuitive to me. Small is beautiful?


Try and plot type I error rate as function of CV for different levels of N1 under a fixed T/R (0.9 is a good choice). I bet ten belgian drachmers that you will be surprised...

Dear HS,

❝ There’s no stopping criterion in Potvin’s method. My protocols stated clearly that there is none in the method and were approved by the BfArM and two IECs. Experiences?


Potvin's method B/C/D contain a stopping criterion. This is when you after stage 1 realise it's game over.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
42 visitors (0 registered, 42 guests [including 15 identified bots]).
Forum time: 20:08 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5